Press enter to see results or esc to cancel.

Greycroft

Greycroft is a leading venture capital firm focused on investments in the Internet and mobile markets.

Continue Reading

next47

next47 is a global venture firm created by Siemens to invest in entrepreneurs who think big and build companies that will change the way we live and work.

Continue Reading

AbbVie Ventures

AbbVie Biotech Ventures supports transformational scientific opportunities aligned with AbbVie’s core R&D interests to gain access to next-generation science.

Continue Reading

Plug and Play

Plug and Play is a global innovation platform that connects startups to corporations, and invests in over 100 companies every year.

Continue Reading

Dolby Family Ventures

Dolby Family Ventures is an early stage venture firm focused on building great technology companies.

Continue Reading

Deerfield Management

Deerfield is an investment management firm that aims to advance healthcare through investment, information and philanthropy.

Continue Reading

BioStar Capital

A strategic venture capital partnership focused on accelerating value creation for medical device technologies in cardiovascular and orthopaedic medicine.

Continue Reading

New Science Ventures

New Science Ventures (NSV) is a stage-agnostic, Connecticut and London-based venture capital firm that invests in companies using novel scientific approaches in the Life Sciences and Information Technology sectors. Specifically, the firm targets investments in companies that are based on fundamental, science-based innovation, satisfy an unmet need and/or have a substantially better value proposition than current …

Continue Reading

MVM Partners

MVM manages several funds with a global perspective on healthcare. The firm invests broadly across the healthcare sector, including in specialty pharmaceuticals, medical technology, diagnostics, life science tools, consumer healthcare, veterinary medicine, healthcare services, and digital health. MVM portfolio companies are based across the US and Europe as well as in the Middle East and …

Continue Reading

Techstars

Operator of a network of accelerators all around the world, offering industry-agnostic and vertical programs

Continue Reading

Optum Ventures

The corporate venture capital arm of Optum, the firm invests in digital health and healthcare-related companies. It is looking for companies that use data and insights to help improve consumers’ access to healthcare services and how care is delivered and paid for, and that make the healthcare system more reliable and easier to navigate. In …

Continue Reading

Redmile Group

Redmile Group, LLC is an employee-owned investment firm that typically invests in healthcare sector.

Continue Reading

General Atlantic

Founded in 1980, General Atlantic (GA) is an American worldwide growth equity firm, providing capital and strategic support for growth companies.

Continue Reading

Greylock Partners

Greylock Partners is one of the oldest venture capital firms, investing in Seed, Series A and beyond companies in the consumer, enterprise software, and infrastructure, as well as semiconductor sectors. In addition to capital, founders also get the benefits of Greylock’s specialist teams who actively help companies with customer development, executive talent, technical talent, and …

Continue Reading

Accel

Accel is an American venture capital firm that works with startups in seed, early, and growth-stage investments. The firm concentrates on the following technology sectors: consumer, infrastructure, media, mobile, SaaS, and security. In addition to the U.S., Accel has investments in other parts of the world, as well. The firm has offices in Silicon Valley, …

Continue Reading

Y Combinator

An American seed accelerator, started in March 2005 by Paul Graham, Jessica Livingston, Trevor Blackwell and Robert Tappan Morris.

Continue Reading

Pfizer Ventures

Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. The firm identifies and invests in emerging companies that are developing transformative medicines and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of the industry.

Continue Reading